1. Home
  2. NRC vs ETON Comparison

NRC vs ETON Comparison

Compare NRC & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Research Corporation (Delaware)

NRC

National Research Corporation (Delaware)

HOLD

Current Price

$16.89

Market Cap

390.8M

Sector

Health Care

ML Signal

HOLD

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$25.88

Market Cap

683.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRC
ETON
Founded
1981
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
390.8M
683.7M
IPO Year
1997
2018

Fundamental Metrics

Financial Performance
Metric
NRC
ETON
Price
$16.89
$25.88
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$39.33
AVG Volume (30 Days)
72.9K
465.1K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
3.88%
N/A
EPS Growth
4707.69
N/A
EPS
50.00
N/A
Revenue
$119,686,000.00
$79,950,000.00
Revenue This Year
N/A
$40.90
Revenue Next Year
N/A
$47.23
P/E Ratio
$0.33
N/A
Revenue Growth
1.81
104.94
52 Week Low
$9.76
$13.09
52 Week High
$22.79
$27.19

Technical Indicators

Market Signals
Indicator
NRC
ETON
Relative Strength Index (RSI) 51.66 68.66
Support Level $16.64 $16.79
Resistance Level $18.29 N/A
Average True Range (ATR) 0.75 1.31
MACD -0.12 0.10
Stochastic Oscillator 35.69 73.61

Price Performance

Historical Comparison
NRC
ETON

About NRC National Research Corporation (Delaware)

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The company operates in the United States and Canada, of which key revenue is derived from the United States.

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.

Share on Social Networks: